Hypothyroidism and Nephrocalcinosis

Summary:

Nephrocalcinosis is found among people with Hypothyroidism, especially for people who are male, 0-1 old.

The study analyzes which people have Nephrocalcinosis with Hypothyroidism. It is created by eHealthMe based on reports of 20 people who have Hypothyroidism from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypothyroidism?

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development) is found to be associated with 1,617 drugs and 2,600 conditions by eHealthMe. Check the latest studies of Hypothyroidism.

What is Nephrocalcinosis?

Nephrocalcinosis (a condition in which calcium levels in the kidneys are increased) is found to be associated with 155 drugs and 257 conditions by eHealthMe. Check the latest studies of Nephrocalcinosis.

On Aug, 06, 2026

20 people who have Hypothyroidism and Nephrocalcinosis are studied.

Would you have Nephrocalcinosis when you have Hypothyroidism?

Gender of people who have Hypothyroidism and experienced Nephrocalcinosis *:

female: 21.05 %
male: 78.95 %

Age of people who have Hypothyroidism and experienced Nephrocalcinosis *:

Common co-existing conditions for these people *:

Maternal Therapy To Enhance Foetal Lung Maturity: 9 people, 45.00%
Depression: 9 people, 45.00%
Thyroid Diseases: 2 people, 10.00%
Stress And Anxiety: 2 people, 10.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.00%
Pain: 2 people, 10.00%
Lung Disorder (lung disease): 2 people, 10.00%
Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 2 people, 10.00%
High Blood Cholesterol: 2 people, 10.00%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 2 people, 10.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Coordination Abnormal (abnormal movement): 9 people, 45.00%
Renal Disorder (kidney disease): 7 people, 35.00%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 6 people, 30.00%
Heart Rate Irregular: 5 people, 25.00%
Urination - Painful: 5 people, 25.00%
Dyspnea (difficult or laboured breathing): 5 people, 25.00%
Atherosclerosis (disorder of the arteries): 5 people, 25.00%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 5 people, 25.00%
Squamous Cell Carcinoma Of Skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin): 5 people, 25.00%
Small Intestinal Haemorrhage (bleeding from small intestine): 5 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Nephrocalcinosis?

- Check whether Nephrocalcinosis is associated with a drug or a condition

Related publications that referenced our studies

Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .

Related studies:

Treatments, associated drugs and conditions:

Hypothyroidism (168,067 reports)
Nephrocalcinosis (1,443 reports)

All the drugs that are associated with Nephrocalcinosis:

Nephrocalcinosis (155 drugs)

All the conditions that are associated with Nephrocalcinosis:

Nephrocalcinosis (257 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Nephrocalcinosis and Hypothyroidism, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.